Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
9 Meters Biopharma, Inc. · Celiac Disease
Phase 2
Completed
171
2017-09
Industry sponsor intelligence
9 Meters Biopharma, Inc.Clinical Pipeline.
Lead-sponsor view of 9 Meters Biopharma, Inc.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 8
- Recruiting
- 0
- Active
- 0
- Completed
- 7
- Results posted
- 0
- Avg enrollment
- 137
Pipeline overview
Programs by phase and activity.
Velocity
9 Meters Biopharma, Inc. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
8phase labels
Early Phase 10
Phase 12
Phase 25
Phase 31
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Larazotide → | 8 | 2 | 5 | 1 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease
9 Meters Biopharma, Inc. · Celiac Disease
Phase 2
Completed
105
2017-09
Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
9 Meters Biopharma, Inc. · Celiac Disease
Phase 2
Completed
42
2017-09
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
9 Meters Biopharma, Inc. · Celiac Disease
Phase 2
Completed
342
2017-09
Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects
9 Meters Biopharma, Inc. · Celiac Disease
Phase 2
Completed
80
2017-09
Safety of Larazotide Acetate in Healthy Volunteers
9 Meters Biopharma, Inc. · Healthy
Phase 1
Completed
24
2017-09
Safety Study of Larazotide Acetate to Treat Celiac Disease.
9 Meters Biopharma, Inc. · Celiac Disease
Phase 1
Completed
21
2017-09
Search sponsor records
All 9 Meters Biopharma, Inc. studies.
This page groups studies where 9 Meters Biopharma, Inc. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
8 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT03569007Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD SymptomsJul 26, 2022NCT00492960Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac DiseaseSep 20, 2017NCT00620451Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac DiseaseSep 20, 2017NCT00889473Study of the Efficacy of Larazotide Acetate to Treat Celiac DiseaseSep 20, 2017NCT01396213A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac DiseaseSep 20, 2017NCT00362856Safety and Tolerability Study of Larazotide Acetate in Celiac Disease SubjectsSep 12, 2017NCT00386490Safety of Larazotide Acetate in Healthy VolunteersSep 12, 2017NCT00386165Safety Study of Larazotide Acetate to Treat Celiac Disease.Sep 11, 2017